Sphera Funds Management Ltd. Uni Qure N.V. Call Options Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$18.7 - $23.07 $3.28 Million - $4.05 Million	175,400 New	175,400 $3.53 Million
Q1 2022 May 16, 2022	SELL	$14.54 - $21.5 $1.45 Million - $2.15 Million	-100,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $4.29 Million - $6.31 Million	-165,000 Reduced 62.26%	100,000 $3.2 Million
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $3.43 Million - $5.34 Million	65,000 Added 32.5%	265,000 $0
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $5.48 Million - $13.7 Million	200,000 New	200,000 $11.9 Million

153

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $270M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.